Close

We are using cookies to give you the best experience on our site. Cookies are files stored in your browser and are used by most websites to help personalise your web experience.

By continuing to use our website without changing the settings, you are agreeing to our use of cookies.

Find out more

Andrographis paniculata trials for rheumatoid arthritis

Sixty people with rheumatoid arthritis were given either Andrographis paniculata tablets containing 30 mg of andrographolides or placebo tablets containing lactose three times a day for 14 weeks.

  • Although there was some improvement in joint tenderness and function in the Andrographis group, there were no differences in the outcomes compared to placebo.
  • Three of the participants in the Andrographis group reported headaches.

Helpline

0800 5200 520

Our new helpline: Call us for free information, help and advice on your type of arthritis.

All calls are recorded for training and quality purposes

More Information Close
For more information, go to www.arthritisresearchuk.org.
Arthritis Research UK fund research into the cause, treatment and cure of arthritis. You can support Arthritis Research UK by volunteering, donating or visiting our shops.